Floatz logo

Treosulfan

Hematologic Neoplasm With Germline SAMD9L Mutation

Fred Hutchinson Cancer CenterSmall moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Hematologic Neoplasm With Germline SAMD9L Mutation cohort.

Asset / SponsorPhaseRating
TACROLIMUS
Fred Hutchinson Cancer Center
Phase 2B
Fludarabine
Fred Hutchinson Cancer Center
Phase 2B
METHOTREXATE
Fred Hutchinson Cancer Center
Phase 2B
Lapine T-Lymphocyte Immune Globulin
Fred Hutchinson Cancer Center
Phase 2CCC

Same molecule, other indications

Treosulfan is also rated in:

myelodysplastic syndromeDormant
BB
Indicative ·
68 / 100
View asset →
Lymphoblastic Leukemia, Acute, Childhood;Dormant
BB
Indicative ·
66 / 100
View asset →
acute biphenotypic leukemiaDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →